Breaking News Instant updates and real-time market news.

PAVM

PAVmed

$1.09 /

-0.04 (-3.54%)

09:33
05/20/19
05/20
09:33
05/20/19
09:33

PAVmed announces first human CarpX procedures

PAVmed announced that the first group of nine patients with carpal tunnel syndrome underwent CarpX procedures as part of the first-in-human clinical safety study PAVmed is conducting in support of its planned U.S. Food and Drug Administration 510(k) re-submission. The procedures were performed at St. George's Hospital in Christchurch, New Zealand. Nine patients with a clinical diagnosis of carpal tunnel syndrome were enrolled in PAVmed's FIH clinical safety study and underwent preoperative testing, including electrodiagnostic testing, according to the study protocol developed in collaboration with the FDA. The patients then underwent successful minimally invasive carpal tunnel release using the CarpX device. Complete division of the transverse carpal ligament, the protocol's effectiveness endpoint, was confirmed by endoscopic visualization of the cut edges of the ligament across its entire width. There were no device-related adverse events. As per the protocol, patients will undergo post-operative clinical follow-up at two weeks and 90 days, with repeat electrodiagnostic testing during the 90-day follow-up to document the protocol's safety endpoint. Another group of patients are scheduled to undergo CarpX procedures in the coming weeks. Once these procedures and 90-day follow-up are completed, PAVmed will resubmit the CarpX 510(k) application incorporating the clinical safety and effectiveness data from the study.

  • 21

    May

PAVM PAVmed
$1.09 /

-0.04 (-3.54%)

01/14/19 Maxim
PAVmed price target lowered to $3 from $4 at Maxim
06/28/18 Maxim
PAVmed initiated with a Buy at Maxim
06/28/18 Maxim
PAVmed initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

Upgrade
Arkema upgraded to Overweight from Neutral at JPMorgan » 21:30
02/25/20
02/25
21:30
02/25/20
21:30
ARKAY

Arkema

$0.00 /

+ (+0.00%)

JPMorgan analyst Chetan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Iovance Biotherapeutics price target raised to $40 from $30 at Piper Sandler » 21:02
02/25/20
02/25
21:02
02/25/20
21:02
IOVA

Iovance Biotherapeutics

$31.61 /

+6.92 (+28.03%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Infinera price target raised to $8.50 from $5.50 at Piper Sandler » 20:56
02/25/20
02/25
20:56
02/25/20
20:56
INFN

Infinera

$7.90 /

-0.2 (-2.47%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Northview REIT downgraded to Market Perform from Outperform at BMO Capital » 20:49
02/25/20
02/25
20:49
02/25/20
20:49
NPRUF

Northview REIT

$0.00 /

+ (+0.00%)

BMO Capital analyst Troy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Ecopetrol reports Q4 net profit up 51.5% at COP4.01T » 20:36
02/25/20
02/25
20:36
02/25/20
20:36
EC

Ecopetrol

$19.14 /

-0.265 (-1.37%)

Reports Q4 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Rayonier Advanced Materials sees FY20 capex down by $10M-$15M » 20:33
02/25/20
02/25
20:33
02/25/20
20:33
RYAM

Rayonier Advanced Materials

$2.40 /

-0.325 (-11.95%)

Rayonier Advanced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Rayonier Advanced Materials reports Q4 EPS (78c), consensus (29c) » 20:32
02/25/20
02/25
20:32
02/25/20
20:32
RYAM

Rayonier Advanced Materials

$2.40 /

-0.325 (-11.95%)

Reports Q4 revenue $468M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Extra Space Storage chairman sells 200K shares of common stock » 20:27
02/25/20
02/25
20:27
02/25/20
20:27
EXR

Extra Space Storage

$106.95 /

-1.86 (-1.71%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Notable companies reporting before tomorrow's open » 20:25
02/25/20
02/25
20:25
02/25/20
20:25
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

, TJX

TJX

$59.77 /

-1.97 (-3.19%)

, WEN

Wendy's

$22.98 /

-0.425 (-1.82%)

, SEAS

SeaWorld

$29.75 /

-2.9 (-8.88%)

, PZZA

Papa John's

$67.51 /

-0.99 (-1.45%)

, AMCX

AMC Networks

$33.01 /

-1.26 (-3.68%)

, CARS

Cars.com

$10.57 /

-1.48 (-12.28%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Lowe's (LOW), consensus 91c... TJX Companies (TJX), consensus 77c... Wendy's (WEN), consensus 8c... SeaWorld (SEAS), consensus 2c... Papa John's (PZZA), consensus 32c... AMC Networks (AMCX), consensus $1.78... Cars.com (CARS), consensus 37c.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley auto analysts to hold an analyst/industry conference call » 20:25
02/25/20
02/25
20:25
02/25/20
20:25
TM

Toyota

$134.02 /

-0.475 (-0.35%)

Auto Analysts discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings rise to 940.09MT from 933.94MT » 20:17
02/25/20
02/25
20:17
02/25/20
20:17
GLD

SPDR Gold Shares

$153.34 /

-2.82 (-1.81%)

This is the largest level…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
Remy Cointreau initiated with a Buy at Goldman Sachs » 20:14
02/25/20
02/25
20:14
02/25/20
20:14
REMYY

Remy Cointreau

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Fevertree Drinks initiated with a Sell at Goldman Sachs » 20:07
02/25/20
02/25
20:07
02/25/20
20:07
FQVTF

Fevertree Drinks

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Campari initiated with a Neutral at Goldman Sachs » 19:58
02/25/20
02/25
19:58
02/25/20
19:58
DVDCY

Campari

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Coca-Cola HBC initiated with a Neutral at Goldman Sachs » 19:55
02/25/20
02/25
19:55
02/25/20
19:55
CCHGY

Coca-Cola HBC

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Olivier Nicolai initiated coverage of Coca-Cola HBC with a Neutral rating and 2940 GBp price target. The analyst notes that the company's current valuation multiple of 21-times expected forward earnings captures the growth potential of its expected 5% organic revenue growth, even though he sees potential opportunities related to its conservative balance sheet and the roll-out of the Costa brand beginning this year.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Heineken initiated with a Neutral at Goldman Sachs » 19:51
02/25/20
02/25
19:51
02/25/20
19:51
HEINY

Heineken

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Carlsberg initiated with a Sell at Goldman Sachs » 19:49
02/25/20
02/25
19:49
02/25/20
19:49
CABGY

Carlsberg

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Olivier Nicolai initiated coverage of Carlsberg with a Sell rating and DKK 930 price target. The analyst notes that the company has had a good track record of higher margins, returns, and growth in recent years, but with the stock trading near an all-time high relative multiples, he sees some scope for downgrades.. Nicolai adds that Carlsberg's further margin pressure in Russia has not been fully captured by consensus.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Diageo initiated with a Buy at Goldman Sachs » 19:45
02/25/20
02/25
19:45
02/25/20
19:45
DGEAF

Diageo

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
AB InBev initiated with a Neutral at Goldman Sachs » 19:40
02/25/20
02/25
19:40
02/25/20
19:40
BUD

AB InBev

$66.85 /

-2.51 (-3.62%)

Goldman Sachs analyst…

Goldman Sachs analyst Olivier Nicolai initiated coverage of AB InBev with a Neutral rating and $77 price target. The analyst believes that the company is able to regain its best-in-class status in the fast-moving consumer goods category given its global footprint, premium brand portfolio, and superior cash generation. However, Nicolai is also concerned with InBev's current macro headwinds, strong USD, and high leverage.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Britvic initiated with a Buy at Goldman Sachs » 19:33
02/25/20
02/25
19:33
02/25/20
19:33
BTVCF

Britvic

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Pernod Ricard initiated with a Buy at Goldman Sachs » 19:30
02/25/20
02/25
19:30
02/25/20
19:30
PDRDY

Pernod Ricard

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Olivier Nicolai initiated coverage of Pernod Ricard with a Buy rating and EUR 195 price target. The analyst cites the company's attractive "growth algorithm" in European consumer staples, organic revenue growth of 6%-7%, and upside from lower tax and finance costs that he contends are not reflected in consensus, anticipating 13% earnings growth through FY24.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 19:05
02/25/20
02/25
19:05
02/25/20
19:05
ACRS

Aclaris Therapeutics

$1.38 /

-0.04 (-2.82%)

, WW

WW

$34.84 /

-2.05 (-5.56%)

, MTDR

Matador

$10.88 /

-1.32 (-10.82%)

, BGS

B&G Foods

$12.78 /

-0.33 (-2.52%)

, ALRM

Alarm.com

$44.82 /

-1.46 (-3.15%)

, NVRO

Nevro

$132.50 /

-3.01 (-2.22%)

, INFN

Infinera

$7.90 /

-0.2 (-2.47%)

, EVH

Evolent Health

$10.18 /

-1.13 (-9.99%)

, PRTK

Paratek Pharmaceuticals

$3.58 /

+0.04 (+1.13%)

, ADMS

Adamas Pharmaceuticals

$4.77 /

-0.47 (-8.97%)

, AKCA

Akcea Therapeutics

$17.09 /

+0.29 (+1.73%)

, SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

, RVLV

Revolve Group

$19.93 /

+1 (+5.28%)

, SUPN

Supernus

$22.93 /

-1.04 (-4.34%)

, PODD

Insulet

$197.03 /

-10.46 (-5.04%)

, SCCO

Southern Copper

$35.05 /

-1.09 (-3.02%)

, TOL

Toll Brothers

$44.28 /

-2.765 (-5.88%)

, VICR

Vicor Corporation

$47.89 /

-0.14 (-0.29%)

, PEN

Penumbra

$176.15 /

-8.13 (-4.41%)

, UIS

Unisys

$15.88 /

-0.405 (-2.49%)

, PLNT

Planet Fitness

$81.51 /

-2.87 (-3.40%)

, SPCE

Virgin Galactic

$33.65 /

-0.51 (-1.49%)

, REAL

RealReal

$14.99 /

+0.03 (+0.20%)

, ORA

Ormat Technologies

$79.94 /

-3.12 (-3.76%)

, IOVA

Iovance Biotherapeutics

$31.61 /

+6.92 (+28.03%)

, EXEL

Exelixis

$19.42 /

-0.76 (-3.77%)

, EVTC

Evertec

$31.36 /

-0.65 (-2.03%)

, CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

, JAZZ

Jazz Pharmaceuticals

$127.50 /

-3.31 (-2.53%)

, CZR

Caesars

$13.33 /

-0.69 (-4.92%)

, AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

, RRGB

Red Robin

$31.32 /

-3.84 (-10.92%)

, VNDA

Vanda Pharmaceuticals

$11.51 /

-0.28 (-2.37%)

, DIS

Disney

$128.24 /

-4.79 (-3.60%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: Aclaris (ACRS) up 8.0%... WW International (WW) up 6.8%... Matador Resources (MTDR) up 6.0%... B&G Foods (BGS) up 5.7%... Alarm.com (ALRM) up 5.3%... Nevro (NVRO) up 3.4%... Infinera (INFN) up 3.4%... Evolent Health (EVH) up 3.1%... Paratek Pharma (PRTK) up 2.8%... Adamas Pharma (ADMS) up 1.9%... Akcea Therapeutics (AKCA) up 1.9%. DOWN AFTER EARNINGS: SmileDirectClub (SDC) down 20.5%... Revolve Group (RVLV) down 18.1%... Supernus Pharma (SUPN) down 15.0%... Insulet (PODD) down 12.1%... Southern Copper (SCCO) down 9.3%... Toll Brothers (TOL) down 9.0%... Vicor Corp (VICR) down 8.7%... Penumbra (PEN) down 6.9%... Unisys (UIS) down 6.1%... Planet Fitness (PLNT) down 5.9%... Virgin Galactic (SPCE) down 5.7%... RealReal (REAL) down 5.1%... Ormat Technologies (ORA) down 3.8%... Iovance Biotherapeutics (IOVA) down 3.1%... Exelixis (EXEL) down 3.1%... Evertec (EVTC) down 3.0%... Salesforce (CRM) down 2.1%... Jazz Pharma (JAZZ) down 1.8%... Caesars (CZR) down 1.6%... Amarin Corp (AMRN) down 1.4%... Red Robin (RRGB) down 1.3%. ALSO LOWER: Vanda Pharma (VNDA) down 7.6% after Phase 3 study of tradipitant did not meet primary endpoint... Disney (DIS) down 1.7% after naming new CEO. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eBay to begin managing payments in U.K. » 19:02
02/25/20
02/25
19:02
02/25/20
19:02
EBAY

eBay

$36.47 /

-0.8 (-2.15%)

As part of modernizing…

As part of modernizing its marketplace and creating a more streamlined experience for customers, eBay is expanding its management of payments to the United Kingdom. As part of the rollout this summer, the company will offer buyers flexibility and choice in payment methods, and give sellers an easier way to manage their businesses. The U.K. is the third market to offer eBay's new payments experience, after the U.S. and Germany. eBay plans to offer buyers in the U.K. a variety of payment options, including credit card, Google Pay and PayPal. Apple Pay will also be available as a payment option on iPhone and iPad.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Kura Oncology price target cut to $30 from $32 at Piper Sandler » 18:47
02/25/20
02/25
18:47
02/25/20
18:47
KURA

Kura Oncology

$12.35 /

-0.19 (-1.52%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Salesforce CEO: I couldn't be more thrilled with our results » 18:44
02/25/20
02/25
18:44
02/25/20
18:44
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

In an interview on…

In an interview on CNBC's Mad Money, Salesforce CEO Marc Benioff said, "We had a great quarter and I couldn't be more thrilled." When asked about the recent leadership change, Benioff said, "Keith Block is ready to move on to the next chapter in his life. He will be staying on as an advisor to me." He finished by stating, "For some of our customers the coronavirus is a serious situation, but for most it has not had an impact yet."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.